These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21824748)

  • 1. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
    Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
    Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
    Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
    Krabbe CA; Pruim J; Scholtens AM; Roodenburg JL; Brouwers AH; Phan TT; Agool A; Dijkstra PU
    J Oral Maxillofac Surg; 2010 Jan; 68(1):21-7. PubMed ID: 20006150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
    Krabbe CA; van der Werff-Regelink G; Pruim J; van der Wal JE; Roodenburg JL
    Head Neck; 2010 Mar; 32(3):368-74. PubMed ID: 19626632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
    Krabbe CA; Dijkstra PU; Pruim J; van der Laan BF; van der Wal JE; Gravendeel JP; Roodenburg JL
    Oral Oncol; 2008 Jan; 44(1):31-6. PubMed ID: 17306603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
    Stoeckli SJ; Steinert H; Pfaltz M; Schmid S
    Head Neck; 2002 Apr; 24(4):345-9. PubMed ID: 11933176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
    Stuckensen T; Kovács AF; Adams S; Baum RP
    J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative
    Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
    Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
    J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
    Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
    Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.